By Jason Derry
The Biotech Feature of the Month at PipelineReview.com provides an overview and discussion relating to the current state of biogenerics in the industry and marketplace. The Feature specifically discusses the major classes of biologics currently having branded products, including erythropoietin, somatotropin, interferon, granulocyte colony stimulating factor (G-CSF), insulin, and thrombolytics. The Feature also discusses the biogenerics related to these classes, along with links to the European Medicines Evaluation Agency guidelines for biologic products, and links to competitive analysis studies relating to particular biogenerics.
Comments